• First prescriptible, wearable system for continuous heart monitoring nets FDA clearance

    11 days ago - By Healio

    LIVMOR, Inc. announced that it received FDA 510 clearance for the LIVMOR Halo AF Detection System, a physician-prescribed wearable solution that provides continuous monitoring of pulse rhythms for the detection of AF.
    Continuous monitoring can significantly enhance the detection of paroxysmal or asymptomatic AF, on demand during the day and automatically overnight, according to a company press release.
    The LIVMOR Halo System is deployed on a Samsung wearable. It can be worn daily and is completely noninvasive. The patient's pulse rhythms recorded by the device can be analyzed for AF
    Read more ...